phase readout
saveNCT06744205: A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older
COMPLETEDupdated 13h ago
community read0 votes
Sponsor: Sanofi Pasteur, a Sanofi Company. Phase: PHASE1. Conditions: Influenza, Healthy Volunteers
view source ↗
comments(0)
5-min edit window · permanent after that